ORPHAN DRUGS: ECULIZUMAB IN THE TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
GUIDELINES IMPACT ON ANTIPSYCHOTICS PRESCRIPTION
GUIDELINE FOR ANALGESIC USE
DRUG DEVELOPMENT AND HEALTH CARE INNOVATION IN THE EUROPEAN MEZZOGIORNO
SENTIA. AN INTENSIVE MEDICINES MONITORING PROGRAMME FOR PROACTIVE SAFETY SURVEILLANCE OF NEUROLEPTIC TREATMENT IN CHILDREN AND ADOLESCENTS. RESULTS FROM TWO YEARS FOLLOW-UP STUDY
ESTUDIO DE EFECTIVIDAD Y SEGURIDAD EN EL TRATAMIENTO A LARGO PLAZO CON OPIOIDES EN DOLOR CRÓNICO
ILLICIT USE OF ANABOLIC ANDROGENIC STEROIDS (AAS) FOR BODY BUILDING AND IDIOSYNCRATIC LIVER INJURY (DILI): A PROSPECTIVE SERIES FROM THE SPANISH AND LATIN-AMERICAN DILI REGISTRY
WEIGHT GAIN AND ANTIPSYCHOTICS. A CASE/NON-CASE APPROACH IN VIGIBASE
RETIRADA DE MEDICAMENTOS POR MOTIVOS DE SEGURIDAD EN ESPAÑA (1999-2007)
BUDGET IMPACT OF HIGH COMPLEXITY TREATMENTS: IS IT SUSTAINABLE
OFF-LABEL USE IN FIVE TERTIARY HOSPITALS: AVAILABLE EVIDENCE AND OUTCOME
INTERVENTION TO IMPROVE THE APPROPRIATE PROTON PUMP INHIBITOR USE IN PRIMARY CARE
PREVALENCE RATE OF INADEQUATE DRUG USE IN ELDERLY PATIENTS HOSPITALIZED IN SURGERY DEPARTMENTS OF CLINICAL HOSPITAL SAN CARLOS IN MADRID, SPAIN
POTENTIAL PRESCRIBING OMISSIONS VS. POLIPHARMACY AMONG ELDERLY PATIENTS
QUALITY OF CLINICAL PRACTICE GUIDELINES FOR PERIPHERAL ARTERIAL DISEASE: A SYSTEMATIC REVIEW
CONTRIBUTION OF THE PAEDIATRIC WORKSHARING PROCEDURE TO THE INFORMATION ON MEDICINES IN THE FIELD OF PSYCHIATRY
BRAIN HISTAMINE H1-RECEPTOR OCCUPANCY OF BILASTINE, A NEW SECOND-GENERATION ANTIHISTAMINE, MEASURED BY POSITRON EMISSION TOMOGRAPHY
ACETYLCHOLINESTERASE INHIBITORS FOR ALZHEIMER DISEASE. A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS
LOW ABUSE POTENTIAL AND OVERALL SUBJECTIVE EFFECTS AFTER THE SUBLINGUAL ADMINISTRATION OF THERAPEUTIC SINGLE DOSES OF TETRAHYDROCANNABINOL, CANNABIDIOL OR THE COMBINATION OF BOTH DRUGS
NON-INFERIORITY CLINICAL TRIAL ON THE EFFICACY AND SAFETY OF CHONDROITIN SULFATE AND GLUCOSAMINE HYDROCHLORIDE IN COMBINATION VS. CELECOXIB IN PATIENTS WITH KNEE OSTEOARTHRITIS
NEW ORAL ANTICOAGULANTS IN THE TREATMENT OF ACUTE VENOUS THROMBOEMBOLISM: A META-ANALYSIS AND INDIRECT TREATMENT COMPARISONS
PHARMACOGENETICS OF PSORIASIS AND RESPONSE TO BIOLOGICAL DRUGS
INFLUENCE OF POLYMORPHISM OF P-GLYCOPROTEIN ON TACROLIMUS PHARMACOKINETICS IN LUNG TRANSPLANT RECIPIENTS
PHARMACOGENETICS IN PERSONALIZED TREATMENT OF PAIN
DOUBLE-BLIND CLINICAL TRIAL TO STUDY THE EFFECT OF SUPPLEMENTATION WITH A FORMULATION OF NUCLEOTIDES (INMUNACTIVE®) ON THE IMMUNE SYSTEM IN HEALTHY VOLUNTEERS UNDER STRESS IN EXPERIMENTAL CONDITIONS
THE EFFECTS OF TREATMENT ON PROGRESSION OF STRUCTURAL CHANGES IN KNEE OSTEOARTHRITIS: DATA FROM THE OSTEOARTHRITIS INITIATIVE PROGRESSION COHORT
BIOEQUIVALENCE CLINICAL TRIAL OF SUNITINIB ASSOCIATED WITH KETOCONAZOL (KET) VS. SUNITINIB (SUN) AS A SINGLE DOSE
CLINICAL TRIAL OF 24-MONTH ON THE EFFECTS OF CHONDROITIN SULFATE ON STRUCTURAL CHANGES IN KNEE OSTEOARTHRITIS PATIENTS AS ASSESSED BY MRI
RELAPSE AND PERSISTENT SUSTAINED VIRAL RESPONSE IN PATIENTS WITH HEPATITIS C WHO RECEIVED DIRECT-ACTING ANTIVIRAL DRUGS
PREVENTION OF PRETERM BIRTH IN PREGNANT WOMEN AT RISK IDENTIFIED BY ULTRASOUND: EVALUATION OF TWO TREATMENT STRATEGIES (PESAPRO STUDY)
MAGICBULLET/COLMER: 18 MONTHS OF FOLLOW-UP EXPERIENCE IN AN INTERNATIONAL MULTICENTER CLINICAL TRIAL COORDINATED BY A SPANISH HOSPITAL
UCICEC-HUVR-IBIS: A 3 YEARS AND A HALF EXPERIENCE IN A CLINICAL TRIAL UNIT SUPPORTING NON COMMERCIAL RESEARCH
PATIENT RECRUITMENT IN CLINICAL TRIALS (CT) AND INVESTIGATORS PROFILE AT RAMON Y CAJAL HOSPITAL: WHICH IS THE BEST WAY TO IMPROVE THEM
STUDY OF THE EFFECT OF CHONDROITIN SULFATE ON PAIN IN KNEE OSTEOARTHRITIS PATIENTS ASSESSED BY FUNCTIONAL MRI: A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL
CONTRIBUTION OF WINE COMPONENTS ON HYDROXYTYROSOL BODY CONCENTRATIONS
PHARMACOLOGY OF MEPHEDRONE IN HUMANS: A PILOT DOSEFINDING STUDY
DAY-TO-DAY CARDIAC RHYTHM MONITORING BY TRANSTELEPHONIC ECG FOR ANTIARRHYTHMIC DRUG ASSESSMENT: THE RAFFAELLO STUDY EXPERIENCE
ANALGESIC TREATMENT EVALUATION IN MODERATE TO SEVERE ACUTE PAIN CLINICAL TRIALS: IS A PLACEBO-CONTROLLED DESIGN FEASIBLE
THROMBOSPONDIN-1: A NOVEL CHONDROITIN SULFATE TARGET FOR OSTEOARTHRITIS TREATMENT
MONOSODIUM URATE CRYSTAL INDUCED MACROPHAGE INFLAMMATION IS ATTENUATED BY CHONDROITIN SULFATE: PRE-CLINICAL MODEL FOR GOUT PROPHYLAXIS
INITIAL DOSE OF GRANULE FORMULATION OF TACROLIMUS IN CONCOMITANCE WITH FLUCONAZOLE: EXPERIENCE IN LUNG TRANSPLANT RECIPIENTS
MANAGEMENT OF BOCEPREVIR AND TACROLIMUS IN A PATIENT WITH LIVER TRANSPLANT AND HEPATITIS C VIRUS RECURRENCE
IMPLEMENTING PHARMACOGENETICS: PHARMARRAY®, ACODOSE® AND PHARMACOGENETIC CONSULTATION
EFFECT OF CYTOCHROME P450 2D6 ON RISPERIDONE PHARMACOKINETICS AND EXTRAPYRAMIDAL SYMPTOMS IN HEALTHY VOLUNTEERS: RESULTS FROM A PHARMACOGENETIC CLINICAL TRIAL
SALIVARY CONCENTRATIONS AND PHARMACOLOGICAL EFFECTS OF 2C-B IN HUMANS
INFLUENCE OF TWO DIFFERENT BREAKFASTS IN BIOAVAILABILITY OF ALBENDAZOLE AND ALBENDAZOLE-SULPHOXIDE IN HEALTHY VOLUNTEERS
EFFECT OF CYP2C8 AND CYP2C9 AND GENDER ON PIOGLITAZONE PHARMACOKINETICS IN HEALTHY VOLUNTEERS
EFFECTS OF POLYMORPHIMS OF CYP3A5 AND ABCB1 GENES ON CHRONIC NEPHROPATHY: COHORT STUDY
EFFECT OF CYP3A5 GENOTYPE ON TACROLIMUS DOSE REQUIREMENT, NEPHROTOXICITY AND ACUTE REJECTION IN KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES.
SEVERE DRUG INDUCED HEPATOPATHY IN AN ANDALUSIAN PUBLIC TYPE II HOSPITAL
MEASURES TAKEN INTO ACCOUNT TO IMPROVE THE PARTICIPATION OF HEALTH PROFESSIONALS INTO THE NATIONAL PHARMACOVIGILANCE SYSTEM: THE PUERTA DEL MAR HOSPITAL EXPERIENCE
DRUG INTERACTION IN PATIENTS WITH MULTIMORBIDITY AND POLYMEDICATION: IMPLICATIONS FOR CLINICAL PRACTICE
CARBAMAZEPINE-INDUCED RENAL FAILURE AND CARDIOVASCULAR MANIFESTATIONS: REPORT OF A CASE AND ASSESSMENT OF CAUSALITY
WHAT DOCTORS THINK ABOUT PHARMACOVIGILANCE IN THE HOSPITAL
HYPERPROLACTINEMIA AND ANTIPSYCHOTIC TREATMENT IN PAEDIATRIC POPULATIONS: SENTIA PHARMACOVIGILANCE SPANISH REGISTRY
CLINICAL RECOMMENDATIONS FOR ANTIBIOTIC USE: ARE WE IN KEEPING WITH THEM
ANGIOEDEMA SECONDARY TO ACEIS AND AIIRAS: A CASE HISTORY
PEDIATRIC SERIOUS ADVERSE DRUG REACTIONS REPORTED IN ANDALUSIA
DO WE REALLY CONSULT THE LABELLING OF DRUGS BEFORE PRESCRIBING THEM A CASE STUDY
SURVEY ON KNOWLEDGE, ATTITUDES AND PRACTICES OF PATIENTS ON SAFETY OF MEDICINES
DRUG-INDUCED LIVER INJURY (DILI) AN INTERNATIONAL CONCEPT WITH NATIONAL VARIATIONS
A CASE OF LEUKOCYTOSIS AND TRYPTIZOL IN CONNECTION WITH PAIN OF CENTRAL ORIGIN
CLINICALLY SEVERE INTERACTION BETWEEN ACENOCUMAROL AND MICONAZOLE
PILOT STUDY OF PROBLEMS RELATED TO MEDICATIONS REPORTED BY CITIZENS
POLYPHARMACY IN HIGHLY DEPENDENT ELDERLY PATIENTS: A SERIES FROM MEDORA'S ELECTRONICAL MEDICAL RECORDS
DRUGS USE IN AN ELDERLY POPULATION
ANTIDEPRESSANT COMBINATIONS: A UTILIZATION STUDY IN PRIMARY CARE
MONITORING EVALUATION AND IMPACT OF CLINICAL PRACTICAL GUIDE OF POSTOPERATIVE PAIN MANAGEMENT ON ADULTS
PERIOPERATIVE MANAGEMENT AND OUTCOMES OF PATIENTS WITH HIGH OR MODERATE THROMBOTIC RISK TREATED WITH ANTITHROMBOTIC THERAPY AND HIP FRACTURE SURGERY
TRENDS OF USE OF DIFFERENT SYSADOA IN PATIENTS WITH OSTEOARTHRITIS: A POPULATION-BASED COHORT STUDY
EFFICACY AND SAFETY OF TRIPLE THERAPY WITH PEGINTERFERON, RIBAVIRIN, AND BOCEPREVIR WITHIN EARLY ACCESS PROGRAM IN SPANISH PATIENTS WITH HEPATITIS C GENOTYPE 1 WITH SEVERE FIBROSIS: SVRW12 ANALISYS
PHARMACIES AND PHARMACOVIGILANCE CENTERS: A RELATIONSHIP ABLE TO REDUCE THE RISK OF DRUGS: CHRONIC DAILY HEADACHE BY MEDICATION OVERUSE (MOH)
EXACERBATIONS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATED WITH INHALED CORTICOSTEROIDS
STUDY TO ASSESS THE EFFECT OF CHONDROITIN SULFATE IN PERIODONTAL DISEASE
ASSOCIATION BETWEEN CHONDROITIN SULPHATE USE AND THE RISK OF TOTAL KNEE ARTRHOPLASTY IN OSTEOARTHITIS PATIENTS: A PROPENSITY-SCORE MATCHED COHORT STUDY
DRUGS FOR ALZHEIMER'S DISEASE: EVOLUTION OF PATIENTS AND TREATMENTS DEPENDING ON THE INITIAL THERAPY
CONCOMITANT PSYCHIATRIC PHARMACOTHERAPY OF PATIENTS TREATED WITH PALIPERIDONE LONG-ACTING. DATA FROM A SECONDARY HOSPITAL
COST SAVINGS IN THE DISPENSATION OF ANTIPSYCHOTICS LONG-ACTING INJECTIONS FROM A HOSPITAL PHARMACY SERVICE
INTERVENTION TYPE ‘AUDIT-FEEDBACK’ TO MODIFY PRESCRIPTION BEHAVIOUR OF ANTIPSYCHOTIC MEDICINES
SCIENTIFIC PRODUCTIVITY OF CLINICAL PHARMACOLOGY DEPARTMENTS IN SPANISH HOSPITALS: EVALUATION TROUGH PUBMED
KNOWLEDGE OF OFF-LABEL DRUG USE IN CHILDREN: NATIONAL PAEDIATRIC SURVEY RESULTS (OL-PED STUDY)
FIRST YEAR OF GENERAL PHARMACOLOGY IN THE BACHELOR DEGREE IN MEDICINE AT SANT PAU TEACHING UNIT OF THE AUTONOMOUS UNIVERSITY OF BARCELONA, SPAIN
CHONDROITIN SULFATE EFFECTS ON IMMUNOREGULATORY NEUROPEPTIDES LEVELS IN OSTEOARTHRITIC PATIENTS WITH SYNOVITIS
CLINICAL RESEARCH PROJECTS SPONSORED BY INSTITUT DE RECERCA HSCSP
CONTRIBUTION OF THE PAEDIATRIC WORKSHARING PROCEDURE TO THE INFORMATION ON MEDICINES IN THE FIELD OF NEPHROLOGY